An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
Frontiers | Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Kratom (Mitragyna speciosa) drug profile | www.emcdda.europa.eu
Frontiers | Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom | ACS Chemical Neuroscience
Neurobiology of Kratom and its main alkaloid mitragynine
Pharmaceutics | Free Full-Text | Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants
Molecules | Free Full-Text | Biased Opioid Ligands
Central nervous system receptor binding data for mitragynine.... | Download Table
The effects of kratom on restraint–stress-induced analgesia and its mechanisms of action - ScienceDirect
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
The science behind kratom's strange leaves
Kratom | National Institute on Drug Abuse (NIDA)
Majumdar Lab - Research Projects
κ-opioid receptor - Wikipedia
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Evaluating kratom alkaloids using PHASE | PLOS ONE
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development | National Institute on Drug Abuse (NIDA)
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects | Journal of Medicinal Chemistry
